5751 - 5775 of 9145 Results
Title
Year
-
OPENTitle: Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodiesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 5End Page: 5Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-020-0879-zBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-020-0879-z.pdfCitation Count: 42
-
OPENTitle: Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene doseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 5Start Page: 2095End Page: 2116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12835Best OA location URL: https://escholarship.org/uc/item/8nk3j1qrCitation Count: 21
-
OPENTitle: mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double‐Blind, Placebo‐Controlled Futility Trial and 1‐Year Biomarker Longitudinal AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 778End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28923Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9018525Citation Count: 39
-
OPENTitle: Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s diseaseJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 28Issue #: 5Start Page: 1720End Page: 1732Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41418-020-00698-4Best OA location URL: https://www.nature.com/articles/s41418-020-00698-4.pdfCitation Count: 11
-
OPENTitle: Frequency and burden of gastrointestinal symptoms in familial dysautonomiaJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 31Issue #: 1Start Page: 109End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00735-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7906911Citation Count: 8
-
OPENTitle: Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of 11C-DTBZ PET Combined with Correlational TractographyJournal Name: Journal of Nuclear MedicinePublisher: Society of Nuclear MedicineVol: 62Issue #: 4Start Page: 545End Page: 552Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2967/jnumed.120.248500Best OA location URL: https://jnm.snmjournals.org/content/jnumed/62/4/545.full.pdfCitation Count: 32
-
OPENTitle: Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trialsJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 3Start Page: 215End Page: 221Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00681-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7341538Citation Count: 16
- Prediction of cognitive progression in Parkinson's disease using three cognitive screening measures2019OPENTitle: Prediction of cognitive progression in Parkinson's disease using three cognitive screening measuresJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 91End Page: 97Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.08.006Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.08.006Citation Count: 43
-
OPENTitle: Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease PenetranceJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 10Start Page: 1755End Page: 1764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28189Citation Count: 87
- Renal Dysfunction Might Be a Marker of Cardiovascular Dysautonomia in Prodromal Α‐Synucleinopathies2020OPENTitle: Renal Dysfunction Might Be a Marker of Cardiovascular Dysautonomia in Prodromal Α‐SynucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 2Start Page: 374End Page: 374Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27840Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7122792Citation Count: 2
-
OPENTitle: Resting‐State Functional Connectivity Predicts STN DBS Clinical ResponseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 662End Page: 671Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28376Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7987812Citation Count: 42
- Genetic analysis of neurodegenerative diseases in a pathology cohort2018RESTRICTEDTitle: Genetic analysis of neurodegenerative diseases in a pathology cohortJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 76Issue #:Start Page: 214.e1End Page: 214.e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.11.007Citation Count: 52
-
OPENTitle: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemicJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049755Best OA location URL: https://doi.org/10.1242/dmm.049755Citation Count: 0
-
OPENTitle: 4319 Team Science in Parkinson’s Research: Connecting Clinicians and Computational TeamsJournal Name: Journal of Clinical and Translational SciencePublisher: Cambridge University Press (CUP)Vol: 4Issue #: s1Start Page: 118End Page: 119Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/cts.2020.359Citation Count: 0
- Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunities2021RESTRICTEDTitle: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunitiesJournal Name: Physiology NewsPublisher: The Physiological SocietyVol:Issue #: Autumn 123Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.36866/123.32Citation Count: 0
- Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)2019RESTRICTEDTitle: Patient-Centered Clinical Trial Design: A Case Study in Parkinson’s Disease (P2.8-008)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-008Citation Count: 0
-
OPENTitle: 0908 Multi-modal Recruitment of Individuals with REM Sleep Behavior Disorder into a Longitudinal Prodromal Parkinson’s StudyJournal Name: SLEEPPublisher: Oxford University Press (OUP)Vol: 46Issue #: Supplement_1Start Page: A400End Page: A400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsad077.0908Best OA location URL: https://academic.oup.com/sleep/article-pdf/46/Supplement_1/A400/50468111/zsad077.0908.pdfCitation Count: 0
- Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)2017RESTRICTEDTitle: Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.s1.002Citation Count: 0
- A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)2018RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0
- Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)2019RESTRICTEDTitle: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050Citation Count: 0
-
OPENTitle: 6 Association Between American Football Play and Parkinson's Disease: Analysis of the Fox Insight Data SetJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 29Issue #: s1Start Page: 415End Page: 416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617723005507Citation Count: 0
- Carepartner Communication on Parkinson Disease Psychosis (4116)2020RESTRICTEDTitle: Carepartner Communication on Parkinson Disease Psychosis (4116)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4116Citation Count: 0
- Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)2017RESTRICTEDTitle: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013Citation Count: 0
- Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)2019RESTRICTEDTitle: Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants (P3.8-006)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-006Citation Count: 0
- Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)2020RESTRICTEDTitle: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402Citation Count: 0